Home > Insider Trading > Filing (0001144204-10-031160)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1326190	Pharmathene Inc	PIP	Pharmaceutical Preparations (2834)	202726770

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
897464	John Pappajohn	C/O Pharmathene, Inc., One Park Place, Suite 450 Annapolis MD 21401		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value Per Share	Acquisiton	2010-05-26	54,344	$1.49	865,508	No	4	P	Direct
Common Stock, $0.0001 Par Value Per Share	Acquisiton	2010-05-27	45,656	$1.51	911,164	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

This amendment includes additional pricing information in footnotes (1) and (2) that was unavailable at the time of the original filing on May 28, 2010. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.50 per share. The reporting person undertakes to provide to PharmAthene, Inc., any security holder of PharmAthene, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by him at each separate price on May 26 and May 27, 2010.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.51 per share.